SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-15-321392
Filing Date
2015-09-16
Accepted
2015-09-16 16:01:32
Documents
16
Period of Report
2015-09-16
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d74363d8k.htm 8-K 15593
2 EX-99.1 d74363dex991.htm EX-99.1 19018
3 EX-99.2 d74363dex992.htm EX-99.2 38486
4 GRAPHIC g74363p02.jpg GRAPHIC 334741
5 GRAPHIC g74363p1.jpg GRAPHIC 181073
6 GRAPHIC g74363p10.jpg GRAPHIC 174096
7 GRAPHIC g74363p11.jpg GRAPHIC 213686
8 GRAPHIC g74363p12.jpg GRAPHIC 194393
9 GRAPHIC g74363p13.jpg GRAPHIC 164175
10 GRAPHIC g74363p3.jpg GRAPHIC 178564
11 GRAPHIC g74363p4.jpg GRAPHIC 238275
12 GRAPHIC g74363p5.jpg GRAPHIC 112592
13 GRAPHIC g74363p6.jpg GRAPHIC 192385
14 GRAPHIC g74363p7.jpg GRAPHIC 98901
15 GRAPHIC g74363p8.jpg GRAPHIC 157740
16 GRAPHIC g74363p9.jpg GRAPHIC 223067
  Complete submission text file 0001193125-15-321392.txt   3461190
Mailing Address 7020 KIT CREEK ROAD SUITE 270 RESEARCH TRIANGLE PARK NC 27709
Business Address 7020 KIT CREEK ROAD SUITE 270 RESEARCH TRIANGLE PARK NC 27709 919-313-9650
AERIE PHARMACEUTICALS INC (Filer) CIK: 0001337553 (see all company filings)

IRS No.: 203109565 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36152 | Film No.: 151110348
SIC: 2836 Biological Products, (No Diagnostic Substances)